PGIM ETF Trust PGIM Total Return Bond ETF (ARCA: PTRB)

Ultime notizie per PGIM ETF Trust PGIM Total Return Bond ETF (ARCA:PTRB)

The Fund seeks to achieve its objective through a mix of current income and capital appreciation as determined by the Fund's subadviser. The Fund invests, under normal circumstances, at least 80 percent of its investable assets in bonds. For purposes of this policy, bonds include all fixed income securities, other than preferred stock, with a maturity at date of issue of greater than one year (including bonds acquired by the Fund with a maturity at date of issue of greater than one year, but a remaining maturity of one year or less). The term investable assets refers to the Fund's net assets plus any borrowings for investment purposes. The Fund's investable assets will be less than its total assets to the extent that it has borrowed money for non-investment purposes, such as to meet anticipated redemptions. The Fund is an actively managed exchange-traded fund (ETF) and therefore does not seek to replicate the performance of any specific index.

Pgim Aaa Clo Etf

PGIM Total Return Bond ETF

PGIM ETF Trust PGIM Total Return Bond ETF

Zimmer Biomet Holdings, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZBH#NYSE">ZBH</a>) reported better-than-expected earnings for the <a href="https://www.benzinga.com/quote/ZBH">first quarter on Monday</a>.
The company posted first-quarter adjusted EPS of $1.81, down from $1.94 a year ago, beating the Street estimates of $1.77. The orthopedic giant reported sales of $1.91 billion, up 1.1% on a reported basis (+2.3% on constant currency), almost in line with the consensus of $1.9 billion.
&#8220;We are proud of our team&#8217;s continued execution and performance to start the year, as we delivered solid first quarter results and advanced our bold innovation agenda,&#8221; said Ivan Tornos, Zimmer Biomet&#8217;s President and Chief Executive Officer.
The company expects fiscal year 2025 adjusted EPS of $7.90-$8.10, down from prior guidance of $8.15-$8.35 versus consensus of $8.19.
The company expects 2025 revenue growth of 5.7% – 8.2% compared to 1%-3.5% expected earlier. It expects a foreign currency exchange impact of 0.0%-0.5%.
Zimmer Biomet shares gained 0.7% to trade at $91.08 on Tuesday.
These analysts made changes to their price targets on Zimmer Biomet following earnings announcement.
<ul>
<li>Baird analyst Jeff Johnson maintained Zimmer Biomet Holdings with an Outperform rating and lowered the price target from $130 to $115.</li>
<li>Wells Fargo analyst Larry Biegelsen maintained the stock with an Equal-Weight rating and lowered the price target from $113 to $98.</li>
<li>JP Morgan analyst Robbie Marcus maintained the stock with an Overweight rating and lowered the price target from $128 to $105.</li>
<li>Morgan Stanley analyst Cecilia Furlong maintained the stock with an Equal-Weight rating and lowered the price target from $115 to $95.</li>
<li>RBC Capital analyst Shagun Singh maintained Zimmer Biomet with an Outperform and lowered the price target from $125 to $112.</li>
<li>Stifel analyst Rick Wise maintained Zimmer Biomet with a Buy and lowered the price target from $138 to $115.</li>
<li>Raymond James analyst Jayson Bedford maintained Zimmer Biomet with an Outperform rating and lowered the price target from $119 to $104.</li>
<li>Goldman Sachs analyst David Roman maintained the stock with a Neutral and lowered the price target from $120 to $104.</li>
</ul>
Considering buying ZBH stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="619" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06142102/image-56-1024x619.png" alt="" class="wp-image-904113" style="width:549px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06142102/image-56-1024x619.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06142102/image-56-300x181.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06142102/image-56-768x464.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06142102/image-56.png 1105w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/05/45192607/jim-cramer-applied-materials-is-an-excellent-company-but-likes-this-tech-stock-more">Jim Cramer Says Applied Materials Is An &#8216;Excellent&#8217; Company, But Likes This Tech Stock More</a> </li>
</ul>
Photo via Shutterstock

Earnings

News

Price Target

Markets

Analyst Ratings

Trading Ideas

These Analysts Lower Their Forecasts On Zimmer Biomet After Q1 Results

WIIM

KLG stock has given up its prior loss. WK Kellogg shares were trading lower after the company reported worse-than-expected Q1 financial results.

PAAS

RGLD

SBSW

Shares of precious metals stocks are trading higher amid strength in gold and silver.

GlobalFoundries Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GFS#NASDAQ">GFS</a>)&nbsp;reported <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/g45216979/globalfoundries-reports-first-quarter-2025-financial-results" rel="noreferrer noopener">fiscal first-quarter 2025</a> results on Tuesday. The company&#8217;s quarterly revenue growth of 2% year-on-year to $1.585 billion aligns with the&nbsp;analyst consensus estimate.
The contract chipmaker&#8217;s adjusted EPS of 34 cents beat the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">analyst consensus estimate</a> of 28 cents.&nbsp;
Smart mobile device revenue declined 14% from a year ago&nbsp;to&nbsp;$586 million.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/02/43623967/globalfoundries-beats-q4-estimates-margins-shrink-935-million-impairment-charge" rel="noreferrer noopener">GlobalFoundries Explores Merger With Taiwan&#8217;s UMC To Strengthen US Semiconductor Industry</a>
Communications infrastructure &amp; data center revenue grew 45% Y/Y to $174 million. Home and industrial IOT revenue increased 6% Y/Y to $328 million. Automotive revenue rose 16% Y/Y to $309 million. Non-wafer revenue grew 8% Y/Y to $188 million.
Margins: The adjusted gross margin declined by 220 bps to 23.9%. The adjusted operating margin increased by 130 bps to 13.4%. The adjusted EBITDA margin declined by 200 bps Y/Y to 35.2%.&nbsp;
As of March 31, 2025, GlobalFoundries generated $331 million in operating cash flow and held $3.7 billion in cash and equivalents.
CEO Tim Breen attributed the quarterly results to design wins and growth in the Automotive, Communications Infrastructure, Datacenter, and Home and Industrial IoT end markets.
Outlook: GlobalFoundries expects second-quarter revenue of $1.425 billion—$1.925 billion versus the&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">$1.670 billion estimate</a>. The company expects adjusted EPS of $0.31-$0.41 versus&nbsp;the&nbsp;$0.35 estimate. The optimistic guidance signifies stable demand despite choppy auto production and a soft smartphone market, Reuters reported Tuesday.
The Trump administration&#8217;s global tariff plans threatened the semiconductor industry. Tariffs on automakers, GlobalFoundries&#8217; third-largest end-market, have already kicked in.
Outgoing CEO Thomas Caulfield&nbsp;mentioned tariffs on foreign-made chips&nbsp;could help U.S. manufacturers&nbsp;like GlobalFoundries by redirecting customers toward chips made in U.S. factories.
Policy uncertainty is also clouding the chip industry, which is bracing for potential changes to the Biden administration&#8217;s CHIPS Act.
Price Action:&nbsp;GFS stock is down 3.57% to $34.60 at the last check on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/upgrades/25/02/43668326/globalfoundries-gains-analyst-upgrade-eyes-growth-in-automotive-and-ai-powered-data-centers" target="_blank" rel="noreferrer noopener">GlobalFoundries Gains Analyst Upgrade, Eyes Growth In Automotive And AI-Powered Data Centers</a></li>
</ul>
Photo by JHVEPhoto via Shutterstock

Guidance

Movers

Tech

Media

GlobalFoundries Q1 Performance Shows Smartphone Slowdown And Tariff Impact

Palantir Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) analysts highlight the company&#8217;s opportunity in AI, government and commercial sectors after<a href="https://www.benzinga.com/news/earnings/25/05/45208000/palantir-q1-earnings-revenue-beat-eps-in-line-customer-count-up-39-company-raises-guidance-citing-surging-and-ferocious-growth"> first-quarter financial results. </a>
<ul>
<li>Bank of America analyst Mariana Perez Mora maintained a Buy rating on Palantir with a $125 price target.</li>
<li>Goldman Sachs analyst Gabriela Borges maintained a Neutral rating and raised the price target from $80 to $90.</li>
<li>Wedbush analyst Dan Ives maintained an Outperform rating and raised the price target from $120 to $140.</li>
</ul>
Read Also: <a href="https://www.benzinga.com/25/05/45221998/palantir-lauds-elon-musks-doge-cuts-calls-it-the-right-thing-for-the-countrygovernment-resembles-a-marbled-wagyu">Palantir Lauds Musk&#8217;s DOGE Cuts, Calls It &#8216;The Right Thing For The Country:&#8217; Government Resembles A &#8216;Marbled Wagyu&#8217;</a>
Bank of America: Palantir&#8217;s first-quarter revenue beat and raised guidance shows accelerated growth, Mora said in a new investor note.
The analyst highlighted that the first-quarter revenue beat came from strong demand for both commercial and government markets.
Mora said the $125 price target is part of a "longer-term valuation methodology" for the stock.
"We think this valuation fairly captures the beneficial position to national security and US government/allies' digital modernization efforts, a leading role in artificial intelligence-powered platforms, opportunistic partnerships, strong balance sheet and strong profitability," Mora said.
Goldman Sachs: Palantir is "still gaining momentum with AI strategy," Borges said in a new investor note.
Borges said the debate on the medium-term ecosystem remains.
"We believe the enterprise ecosystem continues to turn to Palantir as a proven way of executing AI strategy while alternatives are relatively more challenging to adopt," Borges said.
Palantir can also benefit from the defense tech industry, which is on track for "meaningfully more traction,&#8221; Borges adds. "We continue to view Palantir as well positioned to continue to deliver best-in-class growth given the secular trend towards enterprise AI adoption."
Wedbush: Palantir bull Ives raises the price target after the Q1 results. He again refers to the company as the "Messi of AI."
"The company continues to capitalize on the AI demand wave with its AIP product moat gaining further traction moving forward," Ives said.
The analyst said Palantir's multi-million dollar deals in the pipeline show the company's "land and expand strategy" is working.
Ives also highlighted Palantir's traction gains in Europe with a recent NATO partnership.
"We view Palantir as a generation tech name that we see as a trillion market cap over the next three years with PLTR being a core name in the AI Revolution theme over the coming years."
PLTR Price Action: Palantir stock is down 14.1% to $106.30 on Tuesday versus a 52-week trading range of $63.40 to $125.41. Palantir stock is up 41.3% year-to-date in 2025 and up over 320% in the last year.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/25/05/45171636/exclusive-aprils-20-most-searched-tickers-on-benzinga-pro-where-do-tesla-apple-palantir-nvidia-stocks-rank">EXCLUSIVE: April&#8217;s 20 Most-Searched Tickers On Benzinga Pro — Where Do Tesla, Apple, Palantir, Nvidia Stocks Rank?</a></li>
</ul>
Image: Shutterstock

Analyst Color

Reiteration

PLTR

Palantir Stock A 'Core Name In AI Revolution': Analysts Expect $1 Trillion Market Cap In 3 Years

Legendary investor Warren Buffett announced he is stepping down as the CEO of Berkshire Hathaway Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) at the end of 2025, ending a run of leading the conglomerate that has often <a href="https://www.benzinga.com/general/education/25/01/42832123/warren-buffett-beats-sp-500-in-2024-how-oracle-of-omahas-returns-compare-over-past-20-years">outperformed the S&amp;P 500.</a>
Here's a look at how Buffett got started with Berkshire Hathaway and how much investing alongside him could have been worth.
What Happened: Buffett is one of the greatest investors of the current generation. He is known for his buy-and-hold approach to investing and has used that approach in his life, living in the same house<a href="https://www.benzinga.com/news/24/09/41095962/billionaire-warren-buffett-still-lives-in-an-old-corner-house-he-purchased-for-32k-i-couldnt-imagine" target="_blank" rel="noreferrer noopener"> for the past 65 years.</a>
Before his buy-and-hold approach, which is still used today, Buffett was interested in purchasing low-priced stocks in the 1960s, including well-run companies trading at low prices.
"If (the stocks) were cheap enough, he didn't care it was a lousy company and lousy management. He knew he was going to make money anyways because of the cheapness," Berkshire Vice Chairman&nbsp;Charlie Munger&nbsp;said in the "Becoming Warren Buffett Documentary," CNBC&nbsp;<a href="https://www.cnbc.com/2017/12/12/buffett-bought-berkshire-hathaway-shares-for-7-dollars-and-50-cents-each.html" target="_blank" rel="noreferrer noopener">reported</a>.
Buffett&nbsp;<a href="https://www.berkshirehathaway.com/SpecialLetters/WEB%20past%20present%20future%202014.pdf" target="_blank" rel="noreferrer noopener">bought&nbsp;</a>his first shares of textile company Berkshire Hathaway in December 1962 for $7.50 each.
"I bought the first shares of Berkshire in 1962 and it was a northern textile business destined to become extinct eventually," Buffett said. "It was a statistically cheap stock and a terrible business."
Buffett saw an opportunity at a low price.
"Berkshire Hathaway was closing mills, and as they close mills, it would free up some capital, and then they would re-purchase shares. So I bought some stock with the idea that there would be another tender offer at some point, and we would sell the stock at a modest profit," he said.
Buffett was right, as he <a href="https://www.benzinga.com/general/education/24/08/40652464/warren-buffett-celebrates-94th-birthday-with-1-trillion-market-cap-milestone-a-look-back-at-hig" target="_blank" rel="noopener">received an offer </a>from Berkshire Hathaway to buy his 7% stake in the company. When asked at what price he would sell the holdings, Buffett told Berkshire head Seabury Stanton the price would be $11.50. Stanton agreed but later sent a letter with an offer for $11.375.
The Oracle of Omaha was taken aback by the letter and offer, which led him to refuse to tender his shares.
"That was a monumentally stupid decision," Buffett said of this move.
"That made me very mad, so I just started buying more stock. I just felt that I had been double-crossed by the management."
Buffett began buying more shares and eventually took control of Berkshire Hathaway. Seabury was let go from the company.
The textile business proved okay for Buffett for a couple of years before shutting down in 1985 and becoming what Buffett has called one of his worst investments of all time.
Over the years, Berkshire Hathaway became more than just a textile business, <a href="https://www.benzinga.com/general/entertainment/22/03/26224759/warren-buffett-owns-what-10-berkshire-acquisitions-you-may-have-forgotten" target="_blank" rel="noopener">buying up companies </a>such as Geico, See's Candies, Fruit of the Loom, Dairy Queen, and others.
Buffett also used the company's cash to <a href="https://www.benzinga.com/general/education/25/05/45208955/warren-buffetts-giant-berkshire-portfolio-top-10-includes-banks-oil-and-apple">acquire stakes in publicly traded companies</a> such as Coca-Cola Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>), Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Bank of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) and others.
Read Also: <a href="https://www.benzinga.com/25/05/45184410/warren-buffett-to-step-down-as-berkshire-hathaway-ceo-by-end-of-year-asks-board-to-confirm-greg-abel-as-successor">Warren Buffett To Step Down as Berkshire Hathaway CEO by End of Year, Asks Board To Confirm Greg Abel as Successor</a>
Investing $1,000 in Berkshire Hathaway: As Buffett's first investment took place in Berkshire Hathaway in 1962, there's a good chance that if you're reading this, you might not have been born yet or old enough to buy stock.
If you, your parent, or your grandparent were lucky enough to invest in Berkshire Hathaway stock when Buffett did or when he started accumulating more shares, the returns would be incredible.
Investing $1,000 in Berkshire Hathaway in December 1972 for $7.50 a share at the time Buffett bought shares could have purchased 133.33 shares.
The $1,000 investment would be worth $102,421,161.64 today, based on the current price of Berkshire Hathaway shares, which is $768,35.80.
This represents a return of 10,242,016.2%, or more than 10 million percent since Buffett first invested in Berkshire Hathaway.
Berkshire Hathaway is worth more than&nbsp;$1.1 trillion today and one of the 10&nbsp;most valuable public companies in the world.
Buffett's investment style has produced strong annual returns for investors over the years.
While the hypothetical investment could have people wishing they invested back in 1962 with the Oracle of Omaha, the conglomerate owns many businesses and stock holdings that could set the company up for a successful future of annual returns, even without Buffett leading the way as CEO.
You may not be a billionaire like Warren Buffett, but you can uncover hidden gems in the stock market using our proprietary data and pattern recognition — <a href="https://www.benzinga.com/trading-ideas/25/05/45183831/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-63">check out five stocks flying under the radar that deserve your attention.</a>
This article was previously published by Benzinga and has been updated.
Photo: Shutterstock

Education

Management

AAPL

If You Invested $1,000 In Berkshire Hathaway Stock When Warren Buffett Did, Here's How Much You'd Have Now

<a href="https://asia.nikkei.com/Business/Energy/Mitsubishi-Heavy-talks-to-200-suppliers-to-rebuild-Japan-nuclear-reactors">https://asia.nikkei.com/Business/Energy/Mitsubishi-Heavy-talks-to-200-suppliers-to-rebuild-Japan-nuclear-reactors</a>

General

'Mitsubishi Heavy talks to 200 suppliers to rebuild Japan nuclear reactors'- Nikkei Asia

Eighty percent of small American businesses that buy from China will "just die," Flexport CEO Ryan Petersen said during an April 24 appearance on &#8220;<a href="https://www.youtube.com/watch?v=-dgHWv-Dh6Q&amp;t=3326s">The Prof G Pod</a>,&#8221; a podcast hosted by Scott Galloway.
Petersen warned that the U.S.&#8217;s 145% tariff on Chinese imports could lead to &#8220;mass bankruptcies&#8221; and widespread job losses across the country.
Petersen, who founded Flexport in 2013 and raised $935 million in 2022 at an $8 billion valuation, explained that most products affected are not essentials. &#8220;We have customers that buy pizza ovens in China, like for your backyard,&#8221; he said.&nbsp;
Don't Miss:
<ul>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
&#8220;They&#8217;re&nbsp; really cool products. When the price goes up 50% or more, you might go out and buy pizza from Domino&#8217;s or something.&#8221; Petersen suggested the government could ultimately &#8220;back down&#8221; from the trade war as the pressure mounts.
<h2 class="wp-block-heading">Tariff Chaos Hits Small Importers First</h2>
Flexport has already seen a sharp 35% decline in ocean freight bookings from China within a week of the tariff rollout, Peterson<a href="https://x.com/typesfast/status/1912890264135577990"> posted on X</a> on April 17. This early signal reflects growing uncertainty among small importers, many of whom lack the financial buffer to absorb sudden cost hikes.
Business owners across industries are struggling. Chelsey Brown, owner of the home décor company Curio Blvd told the<a href="https://www.ft.com/content/ae8277b7-f8fb-4262-811d-ed8f3d9c70fe"> Financial Times</a> she had to stop operations entirely. Jacob Sendowski, co-founder of Souper Cubes, estimated it would cost millions to relocate production away from China.
Trending: Donald Trump just announced a $500 billion AI infrastructure deal — <a href="https://www.benzinga.com/money/seize-a-share-while-you-still-can-in-the-2-trillion-entertainment-market-with-elf-labs-at-just-2-25-share">here's how you can invest in the entertainment market's next big disruptor at $2.25 per share</a>.
<h2 class="wp-block-heading">De Minimis Change Fuels Tension</h2>
Adding to the pressure, the U.S. eliminated the de minimis exemption on May 2, requiring tariffs on low-value parcels previously exempt. The move will affect over 4 million small shipments from China daily, according to the<a href="https://apnews.com/article/1b52319a85572331baf31cb6287ecddf"> Associated Press</a>, intensifying costs for sellers relying on direct-to-consumer shipping models.
The tariff escalation is already triggering legal pushback. Five small businesses from various states have filed suit in the U.S. Court of International Trade, arguing that the administration&#8217;s use of the International Emergency Economic Powers Act violates the Constitution&#8217;s separation of powers.
<h2 class="wp-block-heading">Economy Shows Signs of Strain</h2>
U.S. gross domestic product shrank <a href="https://www.bea.gov/sites/default/files/2025-04/gdp1q25-adv.pdf">0.3% in Q1 2025</a>—the first contraction in three years—due to falling imports and reduced government spending. This economic downturn is being closely watched as inflation and trade disruptions continue to ripple.
"I may not want to go higher, or I may not want to even go up to that level&#8230; because you want people to buy," President Donald Trump <a href="https://www.youtube.com/watch?v=qXgnqYC83pQ">told reporters</a> on April 17, signaling he might not escalate tariffs further.
See Also: Shark Tank's Kevin O'Leary called Missing Ring his biggest mistake — Don't repeat history—<a href="https://www.benzinga.com/money/big-tech-has-spent-billions-acquiring-ai-smart-home-startups-one-company-stands-to-benefit-and-has-already-made-10-million">invest in RYSE at just $1.90/share.</a>
<h2 class="wp-block-heading">Airlines, Farmers Brace for Fallout</h2>
The pain isn&#8217;t limited to retail. The <a href="https://nypost.com/2025/04/28/business/us-agriculture-industry-in-full-blown-crisis-as-trump-tariffs-shrink-chinese-orders">New York Post</a> reported last week that U.S. farmers are facing a &#8220;full-blown crisis&#8221; after China canceled 12,000 tons of pork orders and slashed soybean purchases by 97% in one week.
In the aviation sector, Southwest Airlines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>) CEO Bob Jordan told<a href="https://www.bloomberg.com/news/articles/2025-04-24/southwest-ceo-says-us-airline-industry-is-already-in-a-recession"> Bloomberg</a> in an interview late last month that the airline industry is already in a recession. &#8220;When consumers are uncertain, they pull back. Consumers can immediately stop spending,&#8221; he said.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market">Invest Where It Hurts — And Help Millions Heal: Invest in Cytonics and help disrupt a $390B Big Pharma stronghold.</a></li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.30/share!</a></li>
</ul>
Image: Shutterstock

Flexport CEO Ryan Petersen Warns Of 'Mass Bankruptcies' As 80% Of Small Businesses Could 'Just Die' Under 145% China Tariffs

<a href="https://www.axios.com/pro/energy-policy/2025/05/06/scoop-white-house-seeks-to-hasten-nuclear-deployment">https://www.axios.com/pro/energy-policy/2025/05/06/scoop-white-house-seeks-to-hasten-nuclear-deployment</a>

'White House seeks to hasten nuclear deployment'- Axios

Tyson Foods Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSN#NYSE">TSN</a>) shares continue to slide lower on Tuesday. This comes after yesterday's decline of more than 7%. Earnings came in at 92 cents, which was slightly ahead of estimates. But the $13.07 billion of revenue was lower than the $13.14 billion analysts were looking for.
Despite today's move, there is a good chance that it could reverse and head higher. This is why we have made it our Stock of the Day.
Sometimes, technical market dynamics can be more important than the fundamental news that has been reported. For example, as you can see on the chart, despite yesterday's news and panic sellers, the stock found a bottom right around $54.25.
It wasn't a coincidence there was support around this level. Levels that had previously been bottoms can become so again if a stock drops back to them.
This happens because of people who sold their shares when it was at support. A number of them regretted their decision to sell when the price rallied afterward. Some of them decided that if and when it was eventually possible, they would buy their shares back if they could do so at their selling price.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="560" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06140745/TysonFoods.2025one-1024x560.png" alt="" class="wp-image-904072" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06140745/TysonFoods.2025one-1024x560.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06140745/TysonFoods.2025one-300x164.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06140745/TysonFoods.2025one-768x420.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06140745/TysonFoods.2025one.png 1489w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Also: <a href="https://www.benzinga.com/government/regulations/25/05/45227387/bessent-signals-imminent-trade-deals-dismisses-recession-fears-as-stocks-rebound">Bessent Signals Imminent Trade Deals, Dismisses Recession Fears As Stocks Rebound</a>
So when Tyson fell back to around $54.25 in January 2025, remorseful sellers from July 2024 came into the market as buyers. The large number of these orders they placed caused support at the same price.
A similar thing just occurred. On Monday, the low trade was right around this price, and the last two times the stock found this support, a rally followed.
Stocks tend to rally after they drop to support. This occurs when the traders and investors who created the support with their buy orders become aggressive.
They are concerned that others who wish to purchase shares will be willing to pay higher prices than they are. They know that if this happens, the sellers will go to them.
These concerned buyers don't want to miss their trades, so they increase the prices they are willing to pay. Other concerned buyers see this and do the same.
This can result in a bidding war that could force the price higher. It happened the past two times with Tyson at this support. It may be about to happen again.
Read Next: • <a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45224883/oil-soars-above-59-as-middle-east-airstrikes-jolt-markets">Oil Soars Above $59 As Middle East Airstrikes Jolt Markets</a>
Photo: Piotr Swat via Shutterstock

Technicals

Stock Of The Day: Will The Tyson Food Rally Continue?

<a href="https://www.ft.com/content/ca3837bb-34e3-4e15-b4e6-f4c927a3af5a ft.com">https://www.ft.com/content/ca3837bb-34e3-4e15-b4e6-f4c927a3af5a &nbsp;ft.com</a>

'UK closes in on US trade pact with lower tariff quotas for cars and steel'- Financial Times

Alto Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTO#NASDAQ">ALTO</a>) is gearing up to announce its quarterly earnings on Wednesday, 2025-05-07. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Alto Ingredients will report an earnings per share (EPS) of $-0.20.
Investors in Alto Ingredients are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Overview of Past Earnings</h3>
The company's EPS missed by $0.05 in the last quarter, leading to a 6.8% increase in the share price on the following day.
Here's a look at Alto Ingredients's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.11</td>
<td>0.03</td>
<td>-0.10</td>
<td>-0.14</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.16</td>
<td>-0.04</td>
<td>-0.05</td>
<td>-0.17</td>
</tr>
<tr>
<td>Price Change %</td>
<td>7.000000000000001%</td>
<td>-38.0%</td>
<td>6.0%</td>
<td>-10.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746554793_0.png" alt="eps graph" />
<h3>Market Performance of Alto Ingredients's Stock</h3>
Shares of Alto Ingredients were trading at $0.88 as of May 05. Over the last 52-week period, shares are down 51.04%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<h3>Analyst Insights on Alto Ingredients</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Alto Ingredients.
The consensus rating for Alto Ingredients is Buy, based on 1 analyst ratings. With an average one-year price target of $5.5, there's a potential 525.0% upside.
<h3>Peer Ratings Comparison</h3>
The following analysis focuses on the analyst ratings and average 1-year price targets of Arq, Rayonier Adv Materials and Aspen Aerogels, three prominent industry players, providing insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Buy trajectory for Arq, with an average 1-year price target of $9.0, suggesting a potential 922.73% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Rayonier Adv Materials, with an average 1-year price target of $11.0, suggesting a potential 1150.0% upside.</li>
<li>Analysts currently favor an Buy trajectory for Aspen Aerogels, with an average 1-year price target of $16.8, suggesting a potential 1809.09% upside.</li>
</ul>
<h3>Key Findings: Peer Analysis Summary</h3>
The peer analysis summary offers a detailed examination of key metrics for Arq, Rayonier Adv Materials and Aspen Aerogels, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Alto Ingredients</td>
<td>Buy</td>
<td>-13.62%</td>
<td>$-1.39M</td>
<td>-17.19%</td>
</tr>
<tr>
<td>Arq</td>
<td>Buy</td>
<td>-3.79%</td>
<td>$9.80M</td>
<td>-0.62%</td>
</tr>
<tr>
<td>Rayonier Adv Materials</td>
<td>Outperform</td>
<td>0.00%</td>
<td>$36.94M</td>
<td>-2.24%</td>
</tr>
<tr>
<td>Aspen Aerogels</td>
<td>Buy</td>
<td>46.15%</td>
<td>$47.13M</td>
<td>2.02%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Alto Ingredients ranks at the bottom for Revenue Growth and Gross Profit among its peers. It is also at the bottom for Return on Equity.
<h3>Delving into Alto Ingredients's Background</h3>
Alto Ingredients Inc is a producer of specialty alcohols and essential ingredients. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include major food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, Western production, and Others.
<h3>Alto Ingredients: Delving into Financials</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Growth: Alto Ingredients's revenue growth over a period of 3 months has faced challenges. As of 31 December, 2024, the company experienced a revenue decline of approximately -13.62%. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.
Net Margin: Alto Ingredients's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of -17.78%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Alto Ingredients's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -17.19%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Alto Ingredients's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -10.27%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a below-average debt-to-equity ratio of 0.51, Alto Ingredients adopts a prudent financial strategy, indicating a balanced approach to debt management.
<a href="https://www.benzinga.com/quote/ALTO/earnings">To track all earnings releases for Alto Ingredients visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALTO

Insights into Alto Ingredients's Upcoming Earnings

RumbleON (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBL#NASDAQ">RMBL</a>) is preparing to release its quarterly earnings on Wednesday, 2025-05-07. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect RumbleON to report an earnings per share (EPS) of $-0.23.
The market awaits RumbleON's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Performance in Previous Earnings</h3>
In the previous earnings release, the company missed EPS by $1.35, leading to a 5.85% increase in the share price the following trading session.
Here's a look at RumbleON's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.23</td>
<td>-0.16</td>
<td>-0.09</td>
<td>-0.33</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-1.58</td>
<td>-0.32</td>
<td>-0.02</td>
<td>-0.29</td>
</tr>
<tr>
<td>Price Change %</td>
<td>6.0%</td>
<td>4.0%</td>
<td>3.0%</td>
<td>13.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746554770_0.png" alt="eps graph" />
<h3>Market Performance of RumbleON's Stock</h3>
Shares of RumbleON were trading at $2.77 as of May 05. Over the last 52-week period, shares are down 50.92%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<h3>Analyst Insights on RumbleON</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on RumbleON.
With 4 analyst ratings, RumbleON has a consensus rating of Neutral. The average one-year price target is $4.25, indicating a potential 53.43% upside.
<h3>Comparing Ratings Among Industry Peers</h3>
In this comparison, we explore the analyst ratings and average 1-year price targets of OneWater Marine and Monro, three prominent industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for OneWater Marine, with an average 1-year price target of $16.75, suggesting a potential 504.69% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Monro, with an average 1-year price target of $18.8, suggesting a potential 578.7% upside.</li>
</ul>
<h3>Peer Metrics Summary</h3>
The peer analysis summary outlines pivotal metrics for OneWater Marine and Monro, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>RumbleON</td>
<td>Neutral</td>
<td>-13.37%</td>
<td>$67.50M</td>
<td>-94.00%</td>
</tr>
<tr>
<td>OneWater Marine</td>
<td>Neutral</td>
<td>-0.98%</td>
<td>$110.41M</td>
<td>-0.10%</td>
</tr>
<tr>
<td>Monro</td>
<td>Neutral</td>
<td>-3.74%</td>
<td>$104.80M</td>
<td>0.65%</td>
</tr>
</tbody>
</table>

Key Takeaway:
RumbleON is at the bottom for Revenue Growth and Gross Profit, with negative percentages. It is also at the bottom for Return on Equity, with a negative percentage.
<h3>Get to Know RumbleON Better</h3>
RumbleON Inc is a USA-based online retailer that allows both consumers and dealers to Buy-Sell-Trade-Finance pre-owned motorcycles in an efficient, fast, transparent, and engaging experience. Its segments include powersports dealership group and vehicle transportation services. The powersports dealership group segment is comprised of powersports dealerships that sell new and pre-owned powersports vehicles; parts, service and accessories; and finance and inventory products for powersports vehicles sold. The vehicle transportation services segment provides nationwide transportation brokerage services between dealerships and auctions.
<h3>RumbleON's Economic Impact: An Analysis</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Challenges: RumbleON's revenue growth over 3 months faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately -13.37%. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: RumbleON's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -20.92%, the company may face hurdles in effective cost management.
Return on Equity (ROE): RumbleON's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -94.0%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -7.11%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: RumbleON's debt-to-equity ratio stands notably higher than the industry average, reaching 16.76. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<a href="https://www.benzinga.com/quote/RMBL/earnings">To track all earnings releases for RumbleON visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

RMBL

A Glimpse of RumbleON's Earnings Potential

Myomo (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MYO#AMEX">MYO</a>) is gearing up to announce its quarterly earnings on Wednesday, 2025-05-07. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Myomo will report an earnings per share (EPS) of $-0.08.
Anticipation surrounds Myomo's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Performance in Previous Earnings</h3>
The company's EPS beat by $0.01 in the last quarter, leading to a 40.77% increase in the share price on the following day.
Here's a look at Myomo's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.02</td>
<td>-0.04</td>
<td>-0.09</td>
<td>-0.1</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.01</td>
<td>-0.03</td>
<td>-0.03</td>
<td>-0.1</td>
</tr>
<tr>
<td>Price Change %</td>
<td>41.0%</td>
<td>20.0%</td>
<td>-13.0%</td>
<td>-9.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746554757_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Myomo were trading at $4.73 as of May 05. Over the last 52-week period, shares are up 18.83%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<h3>Insights Shared by Analysts on Myomo</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Myomo.
The consensus rating for Myomo is Buy, based on 3 analyst ratings. With an average one-year price target of $10.5, there's a potential 121.99% upside.
<h3>Peer Ratings Comparison</h3>
In this analysis, we delve into the analyst ratings and average 1-year price targets of BrainsWay, LENSAR and Sight Sciences, three key industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Buy trajectory for BrainsWay, with an average 1-year price target of $16.0, suggesting a potential 238.27% upside.</li>
<li>Analysts currently favor an Buy trajectory for LENSAR, with an average 1-year price target of $15.5, suggesting a potential 227.7% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Sight Sciences, with an average 1-year price target of $3.6, suggesting a potential 23.89% downside.</li>
</ul>
<h3>Analysis Summary for Peers</h3>
In the peer analysis summary, key metrics for BrainsWay, LENSAR and Sight Sciences are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Myomo</td>
<td>Buy</td>
<td>153.73%</td>
<td>$8.62M</td>
<td>-1.53%</td>
</tr>
<tr>
<td>BrainsWay</td>
<td>Buy</td>
<td>26.41%</td>
<td>$8.51M</td>
<td>2.91%</td>
</tr>
<tr>
<td>LENSAR</td>
<td>Buy</td>
<td>38.22%</td>
<td>$7.11M</td>
<td>-135.52%</td>
</tr>
<tr>
<td>Sight Sciences</td>
<td>Neutral</td>
<td>1.72%</td>
<td>$16.56M</td>
<td>-12.98%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Myomo ranks first in revenue growth among its peers. It has the highest gross profit margin. However, it has the lowest return on equity.
<h3>All You Need to Know About Myomo</h3>
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).
<h3>Myomo's Financial Performance</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Myomo displayed positive results in 3 months. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately 153.73%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of -2.15%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Myomo's ROE stands out, surpassing industry averages. With an impressive ROE of -1.53%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Myomo's ROA stands out, surpassing industry averages. With an impressive ROA of -0.89%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Myomo's debt-to-equity ratio is below the industry average. With a ratio of 0.33, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<a href="https://www.benzinga.com/quote/MYO/earnings">To track all earnings releases for Myomo visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse of Myomo's Earnings Potential

Piedmont Lithium (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLL#NASDAQ">PLL</a>) will release its quarterly earnings report on Wednesday, 2025-05-07. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Piedmont Lithium to report an earnings per share (EPS) of $-0.58.
Anticipation surrounds Piedmont Lithium's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Earnings Track Record</h3>
During the last quarter, the company reported an EPS beat by $0.36, leading to a 4.12% drop in the share price on the subsequent day.
Here's a look at Piedmont Lithium's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.53</td>
<td>-0.57</td>
<td>-0.33</td>
<td>-0.37</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.17</td>
<td>-0.42</td>
<td>-0.65</td>
<td>-0.61</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-4.0%</td>
<td>3.0%</td>
<td>-6.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746554745_0.png" alt="eps graph" />
<h3>Tracking Piedmont Lithium's Stock Performance</h3>
Shares of Piedmont Lithium were trading at $7.27 as of May 05. Over the last 52-week period, shares are down 43.33%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/PLL/earnings">To track all earnings releases for Piedmont Lithium visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Uncovering Potential: Piedmont Lithium's Earnings Preview

Matrix Service (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTRX#NASDAQ">MTRX</a>) is gearing up to announce its quarterly earnings on Wednesday, 2025-05-07. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Matrix Service will report an earnings per share (EPS) of $-0.05.
Anticipation surrounds Matrix Service's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Earnings History Snapshot</h3>
In the previous earnings release, the company beat EPS by $0.02, leading to a 0.71% increase in the share price the following trading session.

<img src="https://www.benzinga.com/files/images/story/2025/1746554710_0.png" alt="eps graph" />
<h3>Performance of Matrix Service Shares</h3>
Shares of Matrix Service were trading at $12.07 as of May 05. Over the last 52-week period, shares are up 2.03%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<a href="https://www.benzinga.com/quote/MTRX/earnings">To track all earnings releases for Matrix Service visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MTRX

A Peek at Matrix Service's Future Earnings

BGSF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BGSF#NYSE">BGSF</a>) will release its quarterly earnings report on Wednesday, 2025-05-07. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate BGSF to report an earnings per share (EPS) of $-0.11.
BGSF bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Earnings History Snapshot</h3>
During the last quarter, the company reported an EPS beat by $0.02, leading to a 8.76% drop in the share price on the subsequent day.
Here's a look at BGSF's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.08</td>
<td>0.11</td>
<td>0.08</td>
<td>-0.04</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.06</td>
<td>0.10</td>
<td>0.07</td>
<td>0.07</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-9.0%</td>
<td>-5.0%</td>
<td>-1.0%</td>
<td>-16.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746554683_0.png" alt="eps graph" />
<h3>Tracking BGSF's Stock Performance</h3>
Shares of BGSF were trading at $3.31 as of May 05. Over the last 52-week period, shares are down 62.54%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<h3>Analysts' Perspectives on BGSF</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on BGSF.
BGSF has received a total of 1 ratings from analysts, with the consensus rating as Buy. With an average one-year price target of $9.0, the consensus suggests a potential 171.9% upside.
<h3>Peer Ratings Comparison</h3>
In this comparison, we explore the analyst ratings and average 1-year price targets of Asure Software, Kelly Services and Kforce, three prominent industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Outperform trajectory for Asure Software, with an average 1-year price target of $17.71, suggesting a potential 435.05% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Kelly Services, with an average 1-year price target of $25.0, suggesting a potential 655.29% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Kforce, with an average 1-year price target of $45.0, suggesting a potential 1259.52% upside.</li>
</ul>
<h3>Peers Comparative Analysis Summary</h3>
The peer analysis summary outlines pivotal metrics for Asure Software, Kelly Services and Kforce, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>BGSF</td>
<td>Buy</td>
<td>-12.45%</td>
<td>$21.47M</td>
<td>-1.19%</td>
</tr>
<tr>
<td>Asure Software</td>
<td>Outperform</td>
<td>10.12%</td>
<td>$24.61M</td>
<td>-1.21%</td>
</tr>
<tr>
<td>Kelly Services</td>
<td>Outperform</td>
<td>-3.34%</td>
<td>$241.50M</td>
<td>-2.46%</td>
</tr>
<tr>
<td>Kforce</td>
<td>Neutral</td>
<td>-6.21%</td>
<td>$88.26M</td>
<td>5.57%</td>
</tr>
</tbody>
</table>

Key Takeaway:
BGSF ranks at the bottom for Revenue Growth and Gross Profit among its peers. It is also at the bottom for Return on Equity. Overall, BGSF's performance is weaker compared to its peers in terms of financial metrics.
<h3>Unveiling the Story Behind BGSF</h3>
BGSF Inc is a national provider of consulting, managed services, and professional workforce solutions. two segments: Property Management and Professional. In the Property Management segment is a provider of office and maintenance talent. The Professional segment provides IT professionals with expertise in SAP, Workday, Peoplesoft, Hyperion, Oracle, One Stream, cyber, project management, managed services, and other IT workforce solutions to client partners on a national basis. The group generates the majority of its revenue from the Professional segment.
<h3>Understanding the Numbers: BGSF's Finances</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3 months period, BGSF faced challenges, resulting in a decline of approximately -12.45% in revenue growth as of 31 December, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of -1.52%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): BGSF's ROE excels beyond industry benchmarks, reaching -1.19%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): BGSF's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of -0.64%, the company showcases efficient use of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 0.63, BGSF adopts a prudent financial strategy, indicating a balanced approach to debt management.
<a href="https://www.benzinga.com/quote/BGSF/earnings">To track all earnings releases for BGSF visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BGSF

A Peek at BGSF's Future Earnings

<a href="https://www.theinformation.com/articles/amazon-shopify-lenders-tighten-trade-risks-mount">https://www.theinformation.com/articles/amazon-shopify-lenders-tighten-trade-risks-mount</a>

AMZN

SHOP

'Amazon, Shopify Lenders Tighten Up As Trade Risks Mount'- The Information

Ares Comml Real Est (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACRE#NYSE">ACRE</a>) is preparing to release its quarterly earnings on Wednesday, 2025-05-07. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Ares Comml Real Est to report an earnings per share (EPS) of $0.08.
The announcement from Ares Comml Real Est is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Earnings Track Record</h3>
In the previous earnings release, the company missed EPS by $0.17, leading to a 5.05% drop in the share price the following trading session.
Here's a look at Ares Comml Real Est's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.02</td>
<td>0.04</td>
<td>0.12</td>
<td>-0.15</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.15</td>
<td>0.07</td>
<td>-0.12</td>
<td>-0.62</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-5.0%</td>
<td>1.0%</td>
<td>2.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746554638_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Ares Comml Real Est were trading at $4.17 as of May 05. Over the last 52-week period, shares are down 40.35%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/ACRE/earnings">To track all earnings releases for Ares Comml Real Est visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACRE

Insights into Ares Comml Real Est's Upcoming Earnings

Arq (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARQ#NASDAQ">ARQ</a>) will release its quarterly earnings report on Wednesday, 2025-05-07. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Arq to report an earnings per share (EPS) of $-0.02.
Investors in Arq are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Performance in Previous Earnings</h3>
The company's EPS missed by $0.01 in the last quarter, leading to a 5.86% drop in the share price on the following day.
Here's a look at Arq's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.02</td>
<td>0.03</td>
<td></td>
<td>-0.07</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.03</td>
<td>0.04</td>
<td>-0.06</td>
<td>-0.09</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-6.0%</td>
<td>3.0%</td>
<td>5.0%</td>
<td>-5.0%</td>
</tr>
</tbody>
</table>

<h3>Tracking Arq's Stock Performance</h3>
Shares of Arq were trading at $4.12 as of May 05. Over the last 52-week period, shares are down 47.38%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<h3>Analyst Opinions on Arq</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Arq.
The consensus rating for Arq is Buy, derived from 1 analyst ratings. An average one-year price target of $9.0 implies a potential 118.45% upside.
<h3>Understanding Analyst Ratings Among Peers</h3>
The following analysis focuses on the analyst ratings and average 1-year price targets of Alto Ingredients, Rayonier Adv Materials and Aspen Aerogels, three prominent industry players, providing insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Buy trajectory for Alto Ingredients, with an average 1-year price target of $5.5, suggesting a potential 33.5% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Rayonier Adv Materials, with an average 1-year price target of $11.0, suggesting a potential 166.99% upside.</li>
<li>Analysts currently favor an Buy trajectory for Aspen Aerogels, with an average 1-year price target of $16.8, suggesting a potential 307.77% upside.</li>
</ul>
<h3>Analysis Summary for Peers</h3>
The peer analysis summary provides a snapshot of key metrics for Alto Ingredients, Rayonier Adv Materials and Aspen Aerogels, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Arq</td>
<td>Buy</td>
<td>-3.79%</td>
<td>$9.80M</td>
<td>-0.62%</td>
</tr>
<tr>
<td>Alto Ingredients</td>
<td>Buy</td>
<td>-13.62%</td>
<td>$-1.39M</td>
<td>-17.19%</td>
</tr>
<tr>
<td>Rayonier Adv Materials</td>
<td>Outperform</td>
<td>0.00%</td>
<td>$36.94M</td>
<td>-2.24%</td>
</tr>
<tr>
<td>Aspen Aerogels</td>
<td>Buy</td>
<td>46.15%</td>
<td>$47.13M</td>
<td>2.02%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Arq is at the bottom for Revenue Growth and Gross Profit, with negative values for both metrics. It is also at the bottom for Return on Equity, with a negative value. Overall, Arq is performing poorly compared to its peers in terms of financial metrics.
<h3>About Arq</h3>
Arq Inc is an environmental technology company principally engaged in the sale of consumable air, water, and soil treatment solutions including activated carbon (AC) and chemical technologies. The company manufactures and sells activated carbon and other chemicals used to capture and remove contaminants for the coal-fired power generation, industrial, municipal water and air, water and soil treatment and remediation markets. Some of the products in its portfolio are Powdered Activated Carbon, Granula Activated Carbon, and Colloidal Carbon Product among others.
<h3>Breaking Down Arq's Financial Performance</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Arq's revenue growth over a period of 3 months has faced challenges. As of 31 December, 2024, the company experienced a revenue decline of approximately -3.79%. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.
Net Margin: Arq's net margin is impressive, surpassing industry averages. With a net margin of -4.95%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Arq's ROE excels beyond industry benchmarks, reaching -0.62%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Arq's ROA excels beyond industry benchmarks, reaching -0.47%. This signifies efficient management of assets and strong financial health.
Debt Management: Arq's debt-to-equity ratio is below the industry average at 0.16, reflecting a lower dependency on debt financing and a more conservative financial approach.
<a href="https://www.benzinga.com/quote/ARQ/earnings">To track all earnings releases for Arq visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

PGIM ETF Trust PGIM Total Return Bond ETF

Notizie

Ultime notizie per PGIM ETF Trust PGIM Total Return Bond ETF (ARCA:PTRB)

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO